戻る
「早戻しボタン」を押すと検索画面に戻ります。 [閉じる]

コーパス検索結果 (１語後でソート)

通し番号をクリックするとPubMedの該当ページを表示します
1  that responds poorly to currently available antiinflammatory therapy.
2  could predict the reversibility of CP after antiinflammatory therapy.
3 hronic inflammation and future directions in antiinflammatory therapy.
4 transmigration as a potential new target for antiinflammatory therapy.
5 ticosteroids are recognized as the preferred antiinflammatory therapy.
6 eed for trials of more focused and effective antiinflammatory therapy.
7 d the Pyk2 pathway as a potential target for antiinflammatory therapy.
8 re, we have focused on PECAM as a target for antiinflammatory therapy.
9  whose agonism is an attractive approach for antiinflammatory therapy.
10 S-1 pathway represents a possible target for antiinflammatory therapies.
11 tworks is providing a new way of identifying antiinflammatory therapies.
12  of RA as well as for preclinical testing of antiinflammatory therapies.
13  in connection with the development of novel antiinflammatory therapies.
14 tool for risk stratification and guidance of antiinflammatory therapies.
15 gression and may benefit from future adjunct antiinflammatory therapies.
16 arget metabolic consequences of conventional antiinflammatory therapies.
17 1b expression could provide a new target for antiinflammatory therapy and critical illness.
18  further establish NF-kappaB as a target for antiinflammatory therapy and provide support for the use
19                                    Effective antiinflammatory therapies are needed for the treatment
20  synovial fibroblasts often persists despite antiinflammatory therapy are not known.
21      Methods: Treatment strategies-including antiinflammatory therapies, biologics, antibiotics, immu
22                        Two weeks of combined antiinflammatory therapy caused significant improvements
23                                              Antiinflammatory therapy decreased the inhomogeneity of
24                        The lack of effective antiinflammatory therapies for people with CF (PWCF) rep
25 ry for the safe and effective development of antiinflammatory therapies for sepsis.
26 tiotemporally controlled antinociceptive and antiinflammatory therapy for arthritis.
27 hat tyloxapol is potentially useful as a new antiinflammatory therapy for CF lung disease, and could
28        To evaluate the potential efficacy of antiinflammatory therapy for HIV dementia, dexamethasone
29 sis factor-alpha (TNF-alpha) is an effective antiinflammatory therapy for several chronic inflammator
30                                              Antiinflammatory therapy has the potential to decrease t
31 tion and suggest IL-1R as a novel target for antiinflammatory therapy in CF and potentially other muc
32 egulator).Objectives: To test losartan as an antiinflammatory therapy in CF using CF human bronchial
33 ch should instruct biomarker development and antiinflammatory therapy in children with CF.
34 y provide an effective clinical approach for antiinflammatory therapy in rheumatoid arthritis.
35                       Combined antiviral and antiinflammatory therapy looks promising for viral bronc
36 omy group); and lateral right atriotomy with antiinflammatory therapy (methylprednisolone 2 mg/kg per
37 mpt clinicians to consider intervention with antiinflammatory therapy, preferably inhaled corticoster
38 itis, colchicine, when added to conventional antiinflammatory therapy, significantly reduced the rate
39  transcription it may be possible to develop antiinflammatory therapies that spare the constitutive e
40                                              Antiinflammatory therapy was associated with a reduction
41                                              Antiinflammatory therapy was associated with a reduction
42 0 kg) or placebo in addition to conventional antiinflammatory therapy with aspirin or ibuprofen.